Related Experiment Video
Updated: Mar 18, 2026

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
A CD30-positive variant of intravascular large B-cell lymphoma presenting as diffuse interstitial lung disease and
Lei Wang1, Yongdeng Cai1, Mengyao Wang1
1Department of Respiratory and Critical Care Medicine, Rizhao Hospital of Traditional Chinese Medicine, Rizhao, China.
Introduction:
Intravascular large B-cell lymphoma (IVLBCL) is a rare and aggressive malignancy defined by the proliferation of neoplastic B-cells within the vascular lumen. While the disease can affect multiple organs, commonly manifesting as skin lesions, neurological deficits, or hepatosplenomegaly, it usually spares the lymph nodes and rarely presents as diffuse interstitial lung disease (DILD). We report a 62-year-old man admitted with recurrent fever and progressive dyspnea. Chest computed tomography revealed extensive bilateral interstitial lung disease, with ultrasonography showing generalized lymphadenopathy with preserved architecture. Although initial therapy led to a favorable response, the patient subsequently relapsed. Lymph node biopsy confirmed IVLBCL, characterized by intravascular and intrasinusoidal lymphoma cell infiltration with well-preserved nodal architecture. Notably, the tumor cells showed diffuse strong CD30 expression (~70%), a rare finding potentially linked to the unusual clinical presentation.
Conclusion:
This case demonstrates that IVLBCL can present with diffuse interstitial lung disease and generalized lymphadenopathy, expanding its recognized phenotypic spectrum. It may represent a variant with CD30-mediated nodal homing and immune activation.

